تأثير الأدوية، الأعشاب الطبية، الفواكه، البن والشاي على الأوعية الدموية الكلوية في مرضى بالفشل الكلوي وبدونه

د/ نشوان صالح محمد الأشول

طبيب عام|| مستشفى النصر العام|| عيادة الأشول للأمراض الطبية والقلبية|| مدينة الضالع|| الجمهورية اليمنية

E-mail: nashwansaleh49@gmail.com  || Orcid: https://orcid.org/0009-0001-1470-0943  || Mobile: 00967771601519

1. Rokni, M., Hamblin, M. R., & Rezaei, N. (2020). Cytokines and COVID-19: Friends or foes? Human Vaccines & Immunotherapeutics, 16(10), 2363-2365. https://doi.org/10.1080/21645515.2020.1799669
2. Fang, S., Ju, D., Lin, Y., & Chen, W. (2022). The role of interleukin-22 in lung health and its therapeutic potential for COVID-19. Frontiers in Immunology, 13, 951107. https://doi.org/10.3389/fimmu.2022.951107
3. Sugiyama, K., Shirai, R., Mukae, H., Ishimoto, H., Nagata, T., Sakamoto, N., Ishii, H., Nakayama, S., Yanagihara, K., Mizuta, Y., & Kohno, S. (2007). Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clinical and Experimental Immunology, 147(3), 540-546.
4. Ge, H., Zhou, Y., Liu, X., Nie, X., Wang, Z., Guo, Y., Chen, W., & Yang, Q. (2012). Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty. Angiology, 63(1), 62-66.
5. Al-Bahrani, A., Taha, S., Shaath, H., & Bakhiet, M. (2007). TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research, 4(1), 31-37.
6. Heitzer, T., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R., & Baldus, S. (2006). Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and anti-inflammatory effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(7), 1648-1652.
7. Antonino, M. J., Mahla, E., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2009). Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary artery disease: Biomarker profile and long-term clopidogrel. American Journal of Cardiology, https://doi.org/10.1016/j.amjcard.2009.01.367
8. Chen, J., Tang, Y., Zhong, Y., Wei, B., Huang, X. R., Ming, P., Tang, K., Xu, A., & Lan, H. (2022). P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage to myofibroblast transition. Molecular Therapy, 30(9), 2074-2087.
9. Li, B., Zhang, Y., Zheng, Y., & Cai, H. (2024). The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice. iScience, 27, 109134. https://doi.org/10.1016/j.isci.2024.109134
10. Eller, P., Eller, K., Wolf, A. M., & Oberhuber, G. (2010). Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. Kidney International, 77(5), 428-435.
11. Arora, M., Chen, L., Paglia, M., Gallagher, A., Allen, M., & Manickam, M. (2006). Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 103(20), 7777-7782.
12. Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic-Plese, S. (2008). Simvastatin inhibits IL-17 secretion by targeting multiple IL-17 regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. Journal of Immunology, 180(10), 6988-6996.
13. Lee, K. J., Moon, J. Y., Choi, H. K., Kim, K. K., & Lee, S. H. (2010). Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance. Clinical and Experimental Immunology, 161(2), 298-305.
14. Meng, X., Zhang, K., Li, J., Dong, X., Meng, J., Zhao, X., & Li, Y. (2012). Statins induce the accumulation of regulatory T cells in atherosclerotic plaque. Molecular Medicine, 18(4), 598-605.
15. Chamani, S., Kooshkaki, O., Moossavi, M., Rastegar, M., Soflaei, S. S., McCloskey, A. P., Banach, M., & Sahebkar, A. (2023). The effects of statins on the function and differentiation of blood cells. Archives of Medical Science, 19(5), 1314-1326. https://doi.org/10.5114/aoms/158546
16. Maneechotesuwan, K., Kasetsinsombat, K., Wamanuttajinda, V., Wongkajornsilp, A., & Barnes, P. J. (2013). Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells. Clinical & Experimental Allergy, 43(2), 212-222.
17. Kim, Y. C., Kim, K. K., & Shevach, E. M. (2010). Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction. Immunology, 130(4), 484-493. https://doi.org/10.1111/j.1365-2567.2010.03398.x
18. Vavlukis, A., Vavlukis, M., Dimovski, A., Petrushevska, G., Eftimov, A., Domazetovska, S., & Mladenovska, K. (2022). Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low to moderate cardiovascular risk. Acta Pharmaceutica, 72(3), 303-315. https://doi.org/10.2478/acph-2022-0018
19. Andrianto, A., A'Yun, M. Q., Suryawan, I. R., & Triastuti, F. (2024). Rosuvastatin administration and its effect on IL-6, IL-1β, and TNF-α cytokine levels in peripheral blood mononuclear cells of type II diabetes mellitus patients with COVID-19. Modern Medicine, 31(1), 27-35. https://doi.org/10.31689/rmm.2024.31.1.27
20. Aguilar, M. S., Perez, H. T., Sanchez, J. J., Rios, J. M. V., Perez, P. M., Mendoza, E. C., Reyna, M. S., Corzo, J. G. T., & Moscoso, A. G. (2013). Effect of rosuvastatin on cytokines after traumatic head injury. Journal of Neurosurgery. https://doi.org/10.3171/2012.12.JNS121084
21. Mausner-Fainberg, K., Luboshits, G., Mor, A., Berrebi, A., & Nussbaum, G. (2008). The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis, 197(2), 829-839. https://doi.org/10.1016/j.atherosclerosis.2007.09.007
22. Li, X. L., Liu, Y., Cao, L. L., Zhang, P., Yan, W. X., Shen, H. H., & Zuo, Z. X. (2013). Atorvastatin modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines. Molecular and Cellular Neuroscience, 56(1), 85-95. https://doi.org/10.1016/j.mcn.2013.03.003
23. Chen, J., Tang, Y., Zhong, Y., Wei, B., Huang, X. R., Tang, P. M. K., Xu, A., & Lan, H. Y. (2022). P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage to myofibroblast transition. Molecular Therapy, 30(9), 2831-2845. https://doi.org/10.1016/j.ymthe.2022.06.019
24. Zhang, B., Swamy, S., Balijepalli, S., Panicker, S., Mooliyil, J., Sherman, M. A., Skare, P., Sui, J., & Wang, T. T. (2019). Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia. FASEB Journal, 33(12), 13294-13309. https://doi.org/10.1096/fj.201901047RR
25. Dai, J., Gu, L., Su, Y., Wang, Q., Zhao, Y., Chen, X., Zhou, W., & Tang, Q. (2018). Inhibition of curcumin on influenza A virus infection and influenza pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK, and NF-kB pathways. International Immunopharmacology, 54, 177-187. https://doi.org/10.1016/j.intimp.2017.11.009
26. Kim, S. G., Veena, M. S., Basak, S. K., Han, E., Tajima, T., Gjertson, D. W., & Meyskens, F. L. (2011). Curcumin treatment suppresses IKK beta kinase activity of salivary cells of patients with head and neck cancer: A pilot study. Clinical Cancer Research, 17(19), 5953-5961. https://doi.org/10.1158/1078-0432.CCR-11-1272
27. Han, S., Xu, J., Guo, X., & Huang, M. (2018). Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Clinical and Experimental Pharmacology and Physiology, 45(1), 84-93. https://doi.org/10.1111/1440-1681.12848
28. Chai, Y. S., Chen, Y. Q., Lin, S. H., Xie, K., Wang, C. J., Yang, Y. Z., & Zheng, F. L. (2020). Curcumin regulates differentiation of naive CD4+ T cells and activates IL-10 immune modulation against acute lung injury in mice. Biomedicine & Pharmacotherapy, 125, 109946. https://doi.org/10.1016/j.biopha.2020.109946
29. Ren, Y., Yang, Z., Sun, Z., Zhang, W., Chen, X., & Nie, S. (2019). Curcumin relieves paraquat-induced lung injury through inhibiting the thioredoxin interacting protein/NLR pyrin domain containing 3-mediated inflammatory pathway. Molecular Medicine Reports, 20(6), 5032-5040. https://doi.org/10.3892/mmr.2019.10742
30. Gupta, K., & Pal, N. (2021). Cardamom: the queen of spices. World Journal of Pharmaceutical and Life Science, 7(8), 147-152.
31. Heimesaat, M. M., Mousavi, S., Weschka, D., & Bereswill, S. (2021). Anti-pathogenic and immune-modulatory effects of peroral treatment with cardamom essential oil in acute murine campylobacteriosis. Microorganisms, 9(1), 169. https://doi.org/10.3390/microorganisms9010169
32. Qiblawi, S., Kausar, M. A., Shahid, S. M. A., Saeed, M., & Alazzeh, A. Y. (2020). Therapeutic intervention of cardamom in cancer and other human diseases. Journal of Pharmaceutical Research International, 32(22), 74-84. https://doi.org/10.9734/JPRI/2020/v32i2230774
33. Dibazar, S. P., Fateh, S., & Daneshmandi, S. (2014). Clove (Syzygium aromaticum) ingredients affect lymphocyte subtypes expansion and cytokine profile responses: An in vitro evaluation. Journal of Food and Drug Analysis, 22(4), 448-454. https://doi.org/10.1016/j.jfda.2014.04.005
34. Bachiege, T. F., Sousa, J. P. B., Bastos, J. K., & Sforcin, J. M. (2012). Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. Journal of Pharmacy and Pharmacology, 64(5), 610-616. https://doi.org/10.1111/j.2042-7158.2011.01440.x
35. Jimoh, O. A., Ayodele, A. D., Ojo, O. A., Okin-Aminu, H. O., & Olarotimi, O. J. (2024). Effects of turmeric, ginger, cinnamon, and garlic essential oils on HSP70, NF-kB, oxidative DNA damage, inflammatory cytokines, and oxidative markers in broiler chickens. Translational Animal Science, 8, txae127. https://doi.org/10.1093/tas/txae127
36. Rodas, L., Martinez, S., Aguilo, A., & Tauler, P. (2020). Caffeine supplementation induces higher IL-6 and IL-10 plasma levels in response to a treadmill exercise test. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/s12970-020-00375-4
37. Kovacs, E. G., Alatshan, A., Budai, M. M., Czimmerer, Z., Biro, E., & Benko, S. (2021). Caffeine has different immunomodulatory effects on the cytokine expression and NLRP3 inflammasome function in various human macrophage subpopulations. Nutrients, 13(7), 2409. https://doi.org/10.3390/nu13072409
38. Kobayashi, M., Shimauchi, T., Hino, R., & Tokura, Y. (2004). Roxithromycin down regulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: Its dual inhibitory effects on ligands and the receptors. Cellular Immunology, 228(1), 27-33. https://doi.org/10.1016/j.cellimm.2004.03.011
39. Kawasaki, S., Takizawa, H., Ohtoshi, T., Takeuchi, N., Kohyama, T., Nakamura, H., Kasama, T., Kobayashi, K., Nakahara, K., Morita, Y., & Yamamoto, K. (1998). Roxithromycin inhibits cytokine production by neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrobial Agents and Chemotherapy, 42(6), 1499-1502.
40. Zimmermann, P., Ziesenitz, V., Curtis, N., & Ritz, N. (2018). The immunomodulatory effects of macrolides: A systematic review of the underlying mechanisms. Frontiers in Immunology, 9, 302. https://doi.org/10.3389/fimmu.2018.00302
41. Ballester, P., Cerda, B., Arcusa, R., Marhuenda, J., Yamedjeu, K., & Zafrilla, P. (2022). Effect of ginger on inflammatory diseases. Molecules, 27(7223). https://doi.org/10.3390/molecules27217223
42. Wozniak, E., Broncel, M., Niedzielski, M., Wozniak, A., & Pabis, P. G. (2023). The effect of lipid lowering therapies on the proinflammatory and anti-inflammatory properties of vascular endothelial cells. PLOS ONE, 18(2), e0280741. https://doi.org/10.1371/journal.pone.0280741
43. Ammon, H. P. T. (2011). Erratum to "Modulation of the immune system by Boswellia Serrata extracts and boswellic acids". Phytomedicine, 18(4), 334. https://doi.org/10.1016/j.phymed.2011.01.009
44. Kunnumakkara, A. B., Banik, K., Bordoloi, D., Harsha, C., Choudhary, Sailo, B. L., Padmavathi, G., Roy, N. K., Gupta, S. C., & Aggarwal, B. B. (2018). Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases. Frontiers in Pharmacology, 9(686). https://doi.org/10.3389/fphar.2018.00686
45. Nandan, A., Sharma, V., Banerjee, P., Sadasivam, K., Venkatesan, S., & Prasher, B. (2022). Deciphering the mechanism of Tinospora Cordifolia extract on Th17 cells through in depth transcription profiling and in silico analysis. Frontiers in Pharmacology, 13(1056677). https://doi.org/10.3389/fphar.2022.1056677
46. Hwalee, H., Ahn, E. K., Hong, S. S., & Oh, J. S. (2017). Anti-inflammatory effects of Tribulusamide D isolated from Tribulus terrestris in lipopolysaccharide-stimulated RAW264.7 macrophages. Molecular Medicine Reports, 16, 4421–4428. https://doi.org/10.3892/mmr.2017.7208
47. Fard, E. A., Fereydouni, Z., Mansouri, K., & Mostafa, A. (2020). Effect of Tribulus terrestris L. on expression of ICAM-1, VCAM-1, E-Selectin and proteome profile of human endothelial cells in vitro. Iranian Journal of Immunology, 17(1), 64–67. https://doi.org/10.22034/iji.2020.80295
48. Matsui, S., Matsumoto, H., Sonoda, Y., Ando, K., Yokota, E. A., Sato, T., & Kasahara, T. (2004). Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and exotoxin 1 in a human lung fibroblast cell line. International Immunopharmacology, 4(1633–1644). https://doi.org/10.1016/j.intimp.2004.07.023
49. Marjanovic, N., Bosnar, M., Michielin, F., Wille, D. R., Anic-Milic, T., Culic, O., Popovic-Grle, S., Bogdan, M., Parnham, M. J., & Haber, V. E. (2011). Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro. Pharmacological Research, 63(5), 389–397. https://doi.org/10.1016/j.phrs.2011.02.001
50. Kovaleva, A. A., Remmelts, H. H. F., Rijkers, G. T., Hoepelman, A. I. M., Biesma, D. H., & Oosterheert, J. J. (2012). Immunomodulatory effects of macrolids during community-acquired pneumonia: A literature review. Journal of Antimicrobial Chemotherapy, 67(350–540). https://doi.org/10.1093/jac/dkr520
51. Al-Ashwal, N. S. (2021). Medicinal herbs and manufactured drugs: For treatment of COVID-19 and its complications in Aden-Yemen. Journal of Medical & Pharmaceutical Sciences, 5(1), 1–28. https://doi.org/10.26389/AJSRP.S091220
52. Channappanavar, R., & Perlman, S. (Eds.). (2017). Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. In Seminars in immunopathology (pp. 1–15). Springer.
53. Monserrat, J., Gomez-Lahoz, A. G., Ortega, M. A., Sanz, J., Munoz, B., Arevalo-Serrano, J., Rodriguez, J. M., Gasalla, J. M., Gasulla, O., & Arranz, A. (2022). Role of innate and adaptive cytokines in the survival of COVID-19 patients. International Journal of Molecular Sciences, 23(10344). https://doi.org/10.3390/ijms231810344
54. Donlan, A. N., Sutherland, T. E., Maria, C., Preissner, S., Bradley, B. T., Carpenter, R. M., et al. (2021). IL-13 is a driver of COVID-19 severity. JCI Insight, 6(15), e150107. https://doi.org/10.1172/jci.insight.150107
55. Shaw, J. A., Meiring, M., Snyders, C., Everson, F., Sigwadhi, L. N., Ngah, V., Tromp, G., & Allwood, B., et al. (2023). Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort. Frontiers in Immunology, 14(1219097). https://doi.org/10.3389/fimmu.2023.1219097
56. Melhus, A. (2001). Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae. Journal of Antimicrobial Chemotherapy, 48(3), 397–402. https://doi.org/10.1093/jac/48.3.397
57. Zou, X., Liu, S., Zou, H., Zhou, W., Fu, H., Wei, J., Zhang, J., Zeng, H., Tan, T., Zhou, W., Wu, H., Chen, X., Zhou, X. (2023). Inflammatory mechanisms of Gingko Biloba extract in improving memory functions through IncRNA-COX2/NF-kB pathway in mice with status epilepticus. CNS Neuroscience & Therapeutics, 29(471–482). https://doi.org/10.1111/cns.14019
58. Trompezinski, S., Bonneville, M., Pernet, I., Denis, A., Schmitt, D., & Viac, J. (2010). Ginkgo Biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate. Archives of Dermatological Research, 302(183–189). https://doi.org/10.1007/s00403-009-0979-x
59. Li, Y., Zhu, X., Wang, K., Zhu, L., Murray, M., & Zhou, F. (2022). The potential of Ginkgo Biloba in the treatment of human diseases and the relationship to Nrf2-mediated antioxidant protection. Journal of Pharmacy and Pharmacology, 74(1689–1699). https://doi.org/10.1093/jpp/rgac036
60. Achete de Souza, G., Vaz de Marqui, S., Matias, J. N., Guiguer, E. L., & Barbalho, S. M. (2020). Effects of Ginkgo Biloba on diseases related to oxidative stress. Planta Medica, 86(376–386). https://doi.org/10.1055/a-1109-3405
61. Marinkovic, G., Hoogenboezem, M., Hoeben, K. A., Ruiter, M. S., Kurakula, K., Rubio, I. O., Vos, M., De Vries, C. J. M., Van Buul, J. D., & De Waard, V. (2014). Inhibition of GTPase Rac1 in endothelium by 6-Merc
62. Jha, V. (2010). Should revascularization be recommended for atherosclerotic renal artery stenosis? J R Coll Physician Edinb, 40(1), 37-38. https://doi.org/10.4997/JRCPE.2010.109
63. Zheng, Z., Ma, T., Lian, X., Gao, J., Wang, W., Weng, W., Lu, X., Sun, W., Cheng, Y., Fu, Y., Rane, M. J., Gozal, E., & Cai, L. (2019). Clopidogrel reduces fibronectin accumulation and improves diabetes-induced renal fibrosis. International Journal of Biological Sciences, 15(1), 239-252. https://doi.org/10.7150/ijbs.29063
64. An, X., Jiang, G., Cheng, C., Lv, Z., Liu, Y., & Wang, F. (2018). Inhibition of platelets by clopidogrel suppressed Ang II-induced vascular inflammation, oxidative stress, and remodeling. Journal of the American Heart Association, 7, e009600. https://doi.org/10.1161/JAHA.118.009600
65. Dolivo, D. M., Reed, C. R., Gargiulo, K. A., Rodrigues, A. E., Galiano, R. D., Mustoe, T. A., & Hong, S. J. (2023). Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms. Biochemical Pharmacology, 214, 115644. https://doi.org/10.1016/j.bcp.2023.115644
66. Al-Ashwal, N. S. M. (2024). Examination of renal vessels by doppler ultrasound to see renal & peri-renal vascular features in patients with or without renal disease. Journal of the Arabian Peninsula Center for Medical and Applied Researches, 1(2), 23-41. https://doi.org/10.56793/pcra23122
67. Quercetin-uses, side effects, and more. (2024, December 10). WebMD. Retrieved from www.webmd.com
68. Mueller, M., Hobiger, S., & Jungbauer, A. (2010). Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chemistry, 122(4), 987-996. https://doi.org/10.1016/j.foodchem.2010.03.041
69. Figueiredo, C. A., Marques, C. R., Costa, R. dos S., da Saliva, H. B. F., & Alcantra-Neves, N. M. (2014). Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: Friend or foe? World Journal of Gastroenterology, 20(18), 5235-5243. https://doi.org/10.3748/wjg.v20.i18.5235
70. Bhatt, D. L., Marso, S. P., & Others. (2002). Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. The American Journal of Cardiology, 90(6), 625-628
71. Al-Ashwal, N. S. (2021). Medicinal herbs and manufactured drugs: For treatment of COVID-19 and its complications in Aden – Yemen. Journal of Medical & Pharmaceutical Sciences, 5(1), 1-28. https://doi.org/10.26389/AJSRP.S091220
72. Smail S. W., Babaei E., Kawa A., Abdulahad W. H. (2023) Serum IL-23, IL-10, and TNF-alpha predict in hospital mortality in covid-19 patients. Front. Immunol. 14:1145840. https://doi.org/10.3389/fimmu.2023.1145840
73. Abdelhafiz A. S., Fouad M. A., Sayed-Ahmed M. M., Kamel M. M., Ali A., Fouda M., Khalil M. A., Abdel-Moneim A. S., Kamal L. M. (2021) Up-regulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients. Virology 563; 74-81. https://doi.org/10.1016/j.virol.2021.08.012
74.  Khanmohammadi S., Rezaei N. (2021) Role of Toll-like receptors in the pathogenesis of COVID-19. J med Virol. 93: 2735-2739. https://doi.org/10.1002/jmv.26826
75. Zhou Q., Zhang L., Dong Y., Wang Y., Zhang B., Zhou S., Huang Q., Wu T., Chen G. (2024) The role of SARS-CoV-2-mediated NF-kB activation in COVID-19 patients. Hypertension Research 47: 375-384. https://doi.org/10.1038/s41440-023-01460-2